Abstract:Cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS)-stimulator of interferon genes (STING) signaling is a significant component of the innate immune system and functions as a vital sentinel mechanism to monitor cellular and tissue aberrations in microbial invasion and organ injury. cGAS, a cytosolic DNA sensor, is specialized in recognizing abnormally localized cytoplasmic double-stranded DNA (dsDNA) and catalyzes the formation of a second messenger cyclic-GMP-AMP (cGAMP), which initiates a cascade of type Ⅰ interferon and inflammatory responses mediated by STING. Micronucleus, a byproduct of chromosomal missegregation during anaphase, is also a significant contributor to cytoplasmic dsDNA. These unstable subcellular structures are susceptible to irreversible nuclear envelope rupture, exposing genomic dsDNA to the cytoplasm, which potently recruits cGAS and activates STING-mediated innate immune signaling and its downstream activities, including type Ⅰ interferon and classical nuclear factor-κB (NF-κB) signaling pathways lead to senescence, apoptosis, autophagy activating anti-cancer immunity or directly killing tumor cells. However, sustained STING activation-induced endoplasmic reticulum stress, activated chronic type Ⅰ interferon and nonclassical NF-κB signaling pathways remodel immunosuppressive tumor microenvironment, leading to immune evasion and facilitating tumor metastasis. Therefore, activated cGAS-STING signaling plays a dual role of suppressing or facilitating tumor growth in tumorigenesis and therapy. This review elaborates on research advances in mechanisms of micronucleus inducing activation of cGAS-STING signaling and its implications in tumorigenesis and therapeutic strategies of malignant tumors.

cGAS-STING signaling in cancer immunity and immunotherapy

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

The multiple faces of cGAS-STING in antitumor immunity: prospects and challenges

The cGAS/STING Pathway: A Novel Target for Cancer Therapy

Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy

Cgas-Sting, an Important Pathway in Cancer Immunotherapy.

cGAS-STING pathway in cancer biotherapy

Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy

Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies

The role and application prospect of cGAS-STING signaling pathway in tumor treatment

Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application

Cancer Immunotherapy Strategies That Target the Cgas-Sting Pathway.

Insight into the Dichotomous Regulation of STING Activation in Immunotherapy

Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy

Cellular functions of cGAS-STING signaling

Therapeutic targeting of cGAS–STING pathway in lung cancer

Cgas and Cancer Therapy: a Double-Edged Sword

Cgas-Sting Signaling in the Tumor Microenvironment.

Epigenetic regulation of cGAS and STING expression in cancer

Role of micronucleus-activated cGAS-STING signaling in antitumor immunity